Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption

preview_player
Показать описание
Jul.21 -- Novartis AG Chief Executive Officer Vasant Narasimhan discusses second-quarter earnings, efforts to find a Covid-19 vaccine, and growth prospects. He speaks on "Bloomberg Markets: European Open" after the Swiss drugmaker trimmed its sales forecast for the year as the coronavirus pandemic hit demand for the eye drug Lucentis and other medicines.
Рекомендации по теме
Комментарии
Автор

1:45 in and they are already talking about "the bottom line". Millions of citizens need help and all the swine capitalist can talk about is "the bottom line".

theveganbeast
Автор

Tell us about Novartis, paying Greek Government Members!

HappyAlexandros